![]() |
Volumn 84, Issue 9, 2005, Pages 621-622
|
Hemolytic uremic syndrome following prolonged gemcitabine therapy: Report of four cases from a single institution. Muller S, Schütt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Moritz T. Ann. Hematol. 2005 Feb; 84(2):110-4 [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
FIBRIN DEGRADATION PRODUCT;
FLUOROURACIL;
FRESH FROZEN PLASMA;
GEMCITABINE;
ACUTE KIDNEY FAILURE;
ADULT;
ASCITES;
BLOOD TRANSFUSION;
CANCER RESISTANCE;
CASE REPORT;
CAUSE OF DEATH;
CLINICAL FEATURE;
DISEASE EXACERBATION;
DOSE CALCULATION;
DOSE RESPONSE;
ECHOGRAPHY;
FATALITY;
FIBRINOLYSIS;
HEMATURIA;
HEMOLYTIC ANEMIA;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HUMAN TISSUE;
HYPERTENSION;
KIDNEY BIOPSY;
LABORATORY TEST;
LETTER;
LUNG EDEMA;
MALE;
PATHOPHYSIOLOGY;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PROTEINURIA;
SHORT COURSE THERAPY;
THROMBOCYTOPENIA;
TREATMENT WITHDRAWAL;
URINALYSIS;
VISCERAL PROLAPSE;
ADULT;
DEOXYCYTIDINE;
FATAL OUTCOME;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
MULTIPLE ORGAN FAILURE;
|
EID: 23944470159
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s00277-005-1049-x Document Type: Letter |
Times cited : (4)
|
References (5)
|